2-178535786-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_001267550.2(TTN):c.100829G>A(p.Gly33610Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,612,500 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.100829G>A | p.Gly33610Asp | missense_variant | Exon 358 of 363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.100829G>A | p.Gly33610Asp | missense_variant | Exon 358 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 151914Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000727 AC: 18AN: 247548Hom.: 0 AF XY: 0.0000744 AC XY: 10AN XY: 134420
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1460586Hom.: 0 Cov.: 38 AF XY: 0.0000261 AC XY: 19AN XY: 726582
GnomAD4 genome AF: 0.000204 AC: 31AN: 151914Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74170
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
- -
not specified Uncertain:1
The p.Gly31042Asp variant in TTN has not been previously reported in individuals with cardiomyopathy, but has been identified in 16/33524 Latino chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/; dbSN P rs373754986). Computational prediction tools and conservation analysis suggest that the variant may impact the protein, though this information is not predict ive enough to determine pathogenicity. In summary, the clinical significance of the p.Gly31042Asp variant is uncertain. -
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 33610 of the TTN protein (p.Gly33610Asp). This variant is present in population databases (rs373754986, gnomAD 0.05%). This missense change has been observed in individual(s) with clinical features of TTN-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 501729). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant is located in the M band of TTN (PMID: 25589632). Non-truncating variants in this region may be relevant for neuromuscular disorders, but have not been definitively shown to cause cardiomyopathy (PMID: 23975875). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1838244:Tibial muscular dystrophy;C1858763:Dilated cardiomyopathy 1G;C1861065:Hypertrophic cardiomyopathy 9;C1863599:Myopathy, myofibrillar, 9, with early respiratory failure;C2673677:Early-onset myopathy with fatal cardiomyopathy Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.G24545D variant (also known as c.73634G>A), located in coding exon 185 of the TTN gene, results from a G to A substitution at nucleotide position 73634. The glycine at codon 24545 is replaced by aspartic acid, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at